Haleon PLC (HLN)
9.55
+0.07
(+0.74%)
USD |
NYSE |
Nov 21, 16:00
9.55
0.00 (0.00%)
After-Hours: 20:00
Haleon Gross Profit Margin (Quarterly): 62.88% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 62.88% |
| June 30, 2024 | 61.62% |
| March 31, 2024 | 62.97% |
| December 31, 2023 | 53.54% |
| September 30, 2023 | 61.33% |
| June 30, 2023 | 62.14% |
| March 31, 2023 | 61.62% |
| Date | Value |
|---|---|
| December 31, 2022 | 58.16% |
| September 30, 2022 | 62.90% |
| June 30, 2022 | 62.40% |
| March 31, 2022 | 61.40% |
| December 31, 2021 | 62.80% |
| September 30, 2021 | 62.53% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
53.54%
Minimum
Dec 2023
62.97%
Maximum
Mar 2024
61.25%
Average
62.14%
Median
Jun 2023
Gross Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 70.27% |
| GSK PLC | 70.08% |
| Smith & Nephew PLC | -- |
| Adaptimmune Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 5.94% |
| Return on Assets | 3.21% |
| Return on Invested Capital | 4.19% |
| Profit Margin (Quarterly) | 17.45% |
| Operating Margin (Quarterly) | 25.36% |
| Return on Net Operating Assets | 3.32% |